Connect with us

Health

Robert F. Kennedy, Jr. Urges ‘Make America Healthy Again’

Published

8 minute read

From Heartland Daily News

AnneMarie Schieber

Despite dropping out of the race for president in August, Robert F. Kennedy, Jr. is turning up the volume on reforming national health care and drug policy and attracting attention to what role he might play in an administration depending on the outcome of the November election.

Kennedy has endorsed former president Donald Trump, and Trump has hinted that there could be a role in his second Trump administration.

Kennedy, who founded the safety advocacy group Children’s Health Defense, recently revealed the scope of his health care recommendations through his “Make America Healthy Again” agenda. Trump named Kennedy to his transition team and pledged to establish a panel of experts to work with Kennedy to investigate the increase of chronic health problems and childhood diseases in the United States (see related articles, pages 8,9).

In a September 5 op-ed in The Wall Street JournalKennedy laid out his 12-point Make America Healthy Again plan. Some of the ideas include reducing conflicts of interest at federal health agencies, implementing drug price caps, setting chemical and pesticide standards, requiring nutrition classes in medical school, redirecting money toward preventative care, rereleasing a presidential fitness standard, and expanding health savings accounts.

Boundary Crossing

Over the years, Kennedy has not hesitated to express his opinions, many of which have challenged long-held positions of the public health establishment on issues from vaccines and childhood obesity to the role of big pharmaceutical companies.

Kennedy’s stances cross ideological boundaries. His support of a single-payer national health care system conflicts with free-market opinions on the right, and his criticism of big-government bullying alienates the left. The nation’s painful experience with the measures taken to stem the spread of COVID-19 has attracted attention to Kennedy’s health care opinions in the wake of his forceful criticisms of those policies.

In a wide-ranging interview with Preferred Health magazine in June, Kennedy lambasted the lockdowns and the people he says profited from them.

“The people who came into the pandemic with a billion dollars, the Bill Gates, the Mark Zuckerbergs, the Bloombergs, the Jeffery Bezos, increased their wealth on average by 30 percent,” Kennedy told the publication.

“The lockdowns were a gift to them, the super-rich,” said Kennedy. “Jeffery Bezos, the richest or second-richest man in the world, was able to close down all of his competitors, 3.3 million businesses, and then give us a two-year training course about how to never use a retail outlet again in our lives. Forty-one percent of the black-owned businesses will never reopen. And he was instrumental because he was censoring the books that were critical of the lockdowns, including one that I wrote.”

Insider Advantage

Kennedy’s criticisms appeal to Craig Rucker, president of the Committee for a Constructive Tomorrow (CFACT).

“Kennedy, by virtue of his family name, is an insider, but his unorthodox views make him a provocative outsider,” said Rucker. “The public-health establishment, against which he has railed for years, failed miserably during the coronavirus pandemic. The ties between HHS and Big Pharma are far too cozy, and we have good reason to believe public health suffers as a consequence. A free spirit like his could be just what the doctor ordered.”

NIH Reform Call

Echoing his criticisms of the pandemic response, Kennedy says he wants to overhaul federal health care agencies, beginning with the National Institutes of Health (NIH).

The NIH suppressed the use of ivermectin and hydroxychloroquine during the early stages of the pandemic, in favor of, first, remdesivir and later the COVID vaccines through emergency use authorization, Kennedy argues. Saying the NIH “has been transformed into an incubator for the pharmaceutical industry,” Kennedy recommends removing much of the NIH’s funding for virology.

“It has stepped away from rigorous, evidence-based science, evidence-based medicine, into kind of a magical world,” Kennedy told Preferred Health. “It needs to have scientific discipline reimposed on the entire field of virology. We ought to be funding the study of the etiology of chronic diseases in our universities.”

Focus Shift

Kennedy has also spoken widely on chronic childhood diseases, some of which he has attributed to vaccines. Kennedy has called for public health authorities to shift their focus from infectious diseases such as COVID and influenza to devote more attention to diabetes, obesity, environmental toxins, and other longer-term concerns.

Kennedy has also cited large-scale factory farming and processed food as contributing to the nation’s health problems.

Peter Pitts, president and co-founder of the Center for Medicine in the Public Interest, says Kennedy brings a fresh perspective to public health debates.

“RFK Jr.’s penchant for not taking things at face value could go a long way toward forcing government public-health agencies to argue on behalf of their beliefs rather than simply relying on a ‘because I said so’ defense,” said Pitts.

Surprising Endorsements

Texas Agriculture Commissioner Sid Miller, a Republican, praised Kennedy’s efforts in a September 26 op-ed for Fox News.

“The role of Big Food, much like Big Pharma, is to prioritize their profits over our health,” wrote Miller. “I enthusiastically support RFK Jr.’s campaign to hold these industries accountable by reforming our food and medicine approval and patenting systems. In this he is uniquely qualified: the $1.7 trillion pharmaceutical industry has unfairly maligned him for decades, and he’s still standing strong.”

In a move that raised eyebrows, Robert Redfield, who headed the Centers for Disease Control and Prevention (CDC) under Trump from 2018 to 2021, endorsed Kennedy’s reform efforts in a Newsweek op-ed in September.

“If the next president prioritizes the National Institutes of Health (NIH) to identify which exposures are contributing to the spike in chronic disease in children, we will finally find out and end what is slowly destroying our children,” wrote Redfield.

Bonner Russell Cohen, Ph.D., ([email protected]) is a senior fellow at the National Center for Public Policy Research.

 

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Kennedy to cut 10,000 HHS employees to reduce ‘bureaucratic sprawl’

Published on

From The Center Square

By 

The changes are expected to reduce the agency’s headcount from 82,000 to 62,000 full-time employees.

Robert F. Kennedy Jr. announced a significant restructuring of the U.S. Department of Health and Human Services on Thursday in a move to streamline the huge federal agency and cut costs.

Kennedy plans to trim about 10,000 employees from the agency’s workforce in addition to employees who left as part of a Deferred Resignation Program, similar to a buy out, earlier this year. The move is expected to save about $1.8 billion.

Kennedy said the restructuring won’t affect the agency’s critical services. When combined with HHS’ other efforts, including early retirement, the changes are expected to reduce the agency’s headcount from 82,000 to 62,000 full-time employees. The restructuring will also align the department with Kennedy’s goals for a healthier U.S. population.

“We aren’t just reducing bureaucratic sprawl. We are realigning the organization with its core mission and our new priorities in reversing the chronic disease epidemic,” Kennedy said. “This Department will do more – a lot more – at a lower cost to the taxpayer.”

Kennedy also said the restructuring of the department’s 28 divisions will get rid of redundant units, consolidating them into “15 new divisions, including a new Administration for a Healthy America, or AHA, and will centralize core functions such as Human Resources, Information Technology, Procurement, External Affairs, and Policy.” Regional offices will be reduced from 10 to 5.

The overhaul will implement the new “HHS priority of ending America’s epidemic of chronic illness by focusing on safe, wholesome food, clean water, and the elimination of environmental toxins. These priorities will be reflected in the reorganization of HHS.”

Kennedy also said the restructuring would improve taxpayers’ experience with HHS by making the agency more responsive and efficient. He also said the changes would ensure that Medicare, Medicaid, and other essential health services remain intact.

The Administration for a Healthy America will combine multiple agencies – the Office of the Assistant Secretary for Health, Health Resources and Services Administration, Substance Abuse and Mental Health Services Administration, Agency for Toxic Substances and Disease Registry, and National Institute for Occupational Safety and Health — into a single, unified entity, Kennedy said.

The Centers for Disease Control and Prevention will get the Administration for Strategic Preparedness and Response, which is responsible for national disaster and public health emergency response.

“Over time, bureaucracies like HHS become wasteful and inefficient even when most of their staff are dedicated and competent civil servants,” Kennedy said. “This overhaul will be a win-win for taxpayers and for those that HHS serves.”

Among the cuts: The U.S. Food and Drug Administration will shed about 3,500 full-time employees. Officials said the reduction won’t affect drug, medical device, or food reviewers, nor will it impact inspectors. The CDC will drop about 2,400 employees. The National Institutes of Health will cut about 1,200 employees. The Centers for Medicare & Medicaid Services will cut about 300 employees. The reorganization won’t affect Medicare and Medicaid services, officials said.

Continue Reading

Health

How the once-blacklisted Dr. Jay Bhattacharya could help save healthcare

Published on

From LifeSiteNews

By Christina Maas

Now seated at the helm of the National Institutes of Health, Dr. Jay Bhattacharya is poised to reshape not only the agency’s research priorities but the very culture that pushed him to the fringe.

Imagine spending your career studying infectious diseases, only to find that the real virus spreading uncontrollably is censorship. That was the reality for Dr. Jay Bhattacharya, a Stanford epidemiologist who committed the unpardonable sin of questioning the COVID-19 lockdown orthodoxy. His punishment? Digital exile, courtesy of Silicon Valley’s Ministry of Truth.

In December 2022, the Twitter Files exposed what many had long suspected: Twitter had quietly placed Bhattacharya’s account on a Trends Blacklist. This ensured that his posts, often critical of lockdowns and mask mandates, would never see the light of day on the platform’s trending topics. In other words, Twitter’s algorithm worked like a digital bouncer, making sure his dissenting opinions never made it past the velvet rope.

And Twitter wasn’t alone. Facebook, ever eager to please its government handlers, scrubbed the Great Barrington Declaration from its pages. That document, co-authored by Bhattacharya and other esteemed scientists, dared to suggest that maybe, just maybe, locking down entire populations wasn’t the best strategy. Instead, it proposed focused protection for the most vulnerable while allowing the rest of society to function. For this, it was sent to the digital equivalent of a gulag.

These experiences took center stage during Bhattacharya’s Senate confirmation hearing for the directorship of the National Institutes of Health (NIH). Republican lawmakers, who suddenly found themselves cast as the last defenders of free speech in scientific discourse, saw his nomination as a win.

During his testimony, Bhattacharya didn’t mince words. He detailed how the Biden administration played an active role in orchestrating the suppression of alternative views. It wasn’t enough for officials to push their own pandemic policies — they needed to ensure that no one, regardless of expertise, could challenge them in the public square.

The Science™ vs. The Science

Bhattacharya’s testimony laid bare an uncomfortable truth: the pandemic was a crisis of speech. “The root problem was that people who had alternative ideas were suppressed,” he told Sen. Ashley Moody (R-Fla.). “I personally was subject to censorship by the actions of the Biden administration during the pandemic.”

In a functioning society, that statement would spark bipartisan outrage. Instead, it barely registered. The people who spent years chanting “trust the science” were never interested in science at all.

Real science thrives on debate, skepticism, and the understanding that no single expert — no matter how credentialed—holds absolute truth. But during COVID, science became The Science™ — a government-approved doctrine enforced by Silicon Valley moderators and federal bureaucrats. Deviate from it, and you weren’t just wrong. You were dangerous.

A government-sanctioned muzzle

Bhattacharya wasn’t silenced in some haphazard, accidental way. The Biden administration actively leaned on social media companies to “moderate” voices like his. In practice, that meant tech executives — most of whom couldn’t tell a virus from a viral tweet — decided which epidemiologists the public was allowed to hear.

He responded with a lawsuit against the administration, accusing it of colluding with Big Tech to crush dissent. But in a ruling as predictable as it was revealing, the Supreme Court dismissed the case, arguing that Bhattacharya and his fellow plaintiffs lacked standing. Meaning: Yes, the government may have pressured private companies into silencing critics, but unless you can prove exactly how that harmed you, don’t expect the courts to care.

The real role of science

Despite everything, Bhattacharya didn’t argue for scientists to dictate policy. Unlike the public health bureaucrats who spent the pandemic issuing commandments from their Zoom thrones, he made it clear: “Science should be an engine for freedom,” he said. “Not something where it stands on top of society and says, ‘You must do this, this or this, or else.’”

That distinction matters. Science informs, but policy is about trade-offs. The problem wasn’t that officials got things wrong — it’s that they refused to admit the possibility. Instead of allowing open debate, they silenced critics. Instead of acknowledging uncertainty, they imposed rules with absolute certainty.

Bhattacharya wasn’t censored because he was wrong. He was censored because he questioned people who couldn’t afford to be.

His confirmation hearing made one thing clear: science wasn’t about data. It was about power. And in Washington, power doesn’t like to be questioned.

Science, money and power

At the heart of the hearing was a fundamental question: Who controls science that people are allowed to talk about? The NIH, with its $48 billion budget, is less a research institution and more a financial leviathan, shaping the direction of American science through the projects it funds (or doesn’t)  fund.

Bhattacharya’s nomination comes at a moment when the battle lines around scientific freedom, government intervention, and public trust in research are more entrenched than ever. The pandemic shattered the illusion that science was above politics. Instead, it exposed just how much political and corporate interests shape what counts as “settled” science.

The irony is thick enough to cut with a knife. The man once branded too dangerous for social media, blacklisted for questioning lockdowns, and effectively erased from mainstream discourse is now being handed a key role in the very government that tried to silence him. Dr. Jay Bhattacharya, once forced to the margins, is now at the center of power.

A new administration has decided that maybe — just maybe — silencing dissenting scientists wasn’t the best pandemic strategy. And in a twist no Hollywood scriptwriter would dare to pitch for being too on-the-nose, Bhattacharya wasn’t being welcomed back into the conversation — he’s being put in charge of it.

Bhattacharya was confirmed following a party-line vote Tuesday evening. The decision came after a similarly partisan endorsement from the Senate Committee on Health, Education, Labor and Pensions (HELP), clearing the final hurdle for President Donald Trump’s nominee.

Equally central to his testimony was Bhattacharya’s call for a sweeping shift in NIH priorities. He proposed a decentralization of research funding, stressing the need for greater inclusion of dissenting voices in the scientific process, an apparent rebuke of the consensus-driven culture that dominated during the pandemic. He emphasized targeting resources toward projects with a clear and measurable impact on public health, dismissing other NIH initiatives as “frivolous.”

Now seated at the helm of the National Institutes of Health, Dr. Jay Bhattacharya is poised to reshape not only the agency’s research priorities but the very culture that pushed him to the fringe. His confirmation, hard-won and unapologetically political, is already shaking the scaffolding of a scientific establishment that long equated conformity with consensus.

Reprinted with permission from Reclaim The Net

Continue Reading

Trending

X